Lubricant eye drop designed for patients with meibomian gland dysfunction

Article

A new lubricant eye drop offers a treatment option for patients with meibomian gland dysfunction.

Hünenberg, Switzerland-A new lubricant eye drop (Systane Balance, Alcon Laboratories) offers a treatment option for patients with meibomian gland dysfunction (MGD).

The drop contains hydroxypropyl guar, borate, sorbitol, propylene glycol, and a proprietary emulsion technology (LipiTech System, Alcon) of mineral oil and an anionic phospholipid that holds the components in suspension to deliver more than 2 hours of relief from symptoms of dry eye. It is available without a prescription at retailers in the United States.

The emulsion technology keeps the mineral oil suspended so it does not float to the surface of the eye, said Kristopher May, OD, an optometrist in private practice in Coldwater, MS, and an adjunct faculty member at the Southern College of Optometry.

David L. Kading, OD, FAAO, in private practice in Seattle, WA, said the lubricant eye drop enhances the oil layer of the tear film and improves stability of patients' vision. Meanwhile, it "anchors itself down" into the basement layer and slowly releases more oil for prolonged relief.

"This really creates that outer layer that helps enhance the tear film so it doesn't evaporate as rapidly," said Dr. Kading, who also is an adjunct faculty member at Pacific University College of Optometry.

"Most patients were using an artificial tear every 2 hours, but with [this drop] they seem to get relief with using it two to three times a day," Dr. Todd said. "Women who wear eye makeup or contact lenses like this.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Arkansas Optometric Association legislative cochairs Matt Jones, OD; Matt Burns, OD; and Joe Sugg, OD, discuss their involvement in their bill and provide context for its relevance.
Elise Kramer, OD, FAAO, FSLS, describes her take on a multidisciplinary approach to dry eye
Dana Shannon, OD, FAAO, shares pearls on spotting red flags in need of referral and enhancing patient care with follow-up compliance.
Dana Shannon, OD, FAAO, detailed a lecture she gave at the NOA Midwestern Symposium earlier this month.
CRU 2025 provided the latest insights regarding glaucoma, dry eye disease, retina, myopia, neurotrophic keratitis, and keratoconus.
Rachelle Lin, OD, MS, FAAO
Paul Karpecki, OD, FAAO
Melissa Barnett, OD, FAAO, FSLS, FBCLA, gave 2 presentations alongside other ODs and MDs at CRU 2025.
Rachelle Lin, OD, MS, FAAO, at CRU Eye Symposium 2025
Melissa Tawa, OD, FAAO, provides insights to take glaucoma management from reactive to proactive in presentations given at CRU 2025 in Napa, California.
© 2025 MJH Life Sciences

All rights reserved.